(ALINS) Intrasense - Ratings and Ratios

Intrasense SA (ALINS:PA) specializes in developing advanced software solutions for medical imaging visualization and analysis under the Myrian brand. The company provides a suite of tools tailored for healthcare professionals, researchers, and industrial clients. Its product portfolio includes Myrian Imaging Layer, a multimodal visualization platform; Myrian Studio, a development environment for medical imaging applications; and Myrian Clinical Apps, a range of specialized clinical applications such as Myrian XP-Breast, XP-Prostate, and XP-Lung, designed for advanced post-processing and diagnostics. The company also focuses on biomarker development and AI-driven solutions for medical imaging. Founded in 2004 and headquartered in Montpellier, France, Intrasense operates at the intersection of healthcare and technology, serving clients globally.

From a technical standpoint, Intrasense shares are trading at €0.25 with a 20-day average volume of 16,960. The stock shows a flat trend with SMA 20 and SMA 50 at €0.25, while the SMA 200 is slightly higher at €0.28. The ATR of €0.01 indicates low volatility. Fundamentally, the company has a market cap of €12.90M, a P/B ratio of 2.57, and a P/S ratio of 5.53, reflecting its position as a small-cap healthcare technology firm.